Prosonix Limited

United Kingdom

Back to Profile

1-11 of 11 for Prosonix Limited Sort by
Query
Aggregations
IP Type
        Patent 10
        Trademark 1
Jurisdiction
        World 10
        Canada 1
IPC Class
A61K 9/16 - AgglomeratesGranulatesMicrobeadlets 5
A61K 9/00 - Medicinal preparations characterised by special physical form 4
B01D 9/00 - Crystallisation 4
A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine 3
A61K 31/4015 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide 2
See more
NICE Class
35 - Advertising and business services 1
42 - Scientific, technological and industrial services, research and design 1

1.

METHOD OF FORMING CONCENTRATED SOLUTION

      
Application Number GB2015052763
Publication Number 2016/046553
Status In Force
Filing Date 2015-09-24
Publication Date 2016-03-31
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Burns, John
  • Parikh, Dipesh

Abstract

The present invention relates to a method of forming a concentrated solution of first and second pharmacologically active ingredients which involves: providing a solid eutectic composition of the first and second pharmacologically active ingredients; providing a first solvent; and dissolving the eutectic composition in the first solvent; wherein the first and second pharmacologically active ingredients are independently selected from β2 agonists, muscarinic antagonists, anticholinergics, corticosteroids, methylxanthine compounds and salts, esters, polymorphs, hydrates or solvates thereof. A solution obtainable by this method is also described, along with an ampoule for a nebuliser and a pressurised metered dose inhaler comprising the solution. The solution is useful in the treatment of respiratory diseases.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 9/08 - Solutions
  • A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
  • A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
  • A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

2.

PHARMACEUTICAL COMPOSITIONS COMPRISING MULTI-COMPONENT CRYSTALLINE PARTICLES SUITABLE FOR USE IN INHALATION THERAPY

      
Application Number GB2014050233
Publication Number 2014/118532
Status In Force
Filing Date 2014-01-29
Publication Date 2014-08-07
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Burns, John
  • Parikh, Dipesh

Abstract

Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy and for delivery by oral or nasal inhalation are provided, wherein said compositions additionally comprise particles of at least one additional active agent. Also provided are methods of preparation of the compositions and their use in medicine.

IPC Classes  ?

  • A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
  • A61K 31/4015 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
  • A61K 31/4196 - 1,2,4-Triazoles
  • A61P 11/00 - Drugs for disorders of the respiratory system

3.

MULTI-COMPONENT CRYSTALLINE PARTICLES FOR INHALATION THERAPY

      
Application Number GB2014050231
Publication Number 2014/118530
Status In Force
Filing Date 2014-01-29
Publication Date 2014-08-07
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Burns, John
  • Parikh, Dipesh
  • Karki, Shyam

Abstract

Pharmaceutical Preparations Multi-component crystalline particles and compositions, methods for their preparation, their uses in inhalation therapy and inhaler devices containing said particles are provided, in particular particles comprising glycopyrrolate. The particles can be prepared substantially free of excipients and agents other than active agents or their precursors in the presence of ultrasonic irradiation in a process comprising contacting a solution in a first flowing stream with an anti-solvent in a re-circulating second flowing stream, causing the mixing thereof and collecting crystals that are generated.

IPC Classes  ?

  • A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
  • A61K 31/4015 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
  • A61K 31/4196 - 1,2,4-Triazoles
  • A61P 11/00 - Drugs for disorders of the respiratory system

4.

EUTECTIC MIXTURE FOR PULMONARY ADMINISTRATION

      
Application Number GB2012051924
Publication Number 2013/021199
Status In Force
Filing Date 2012-08-08
Publication Date 2013-02-14
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Ruecroft, Graham
  • Parikh, Dipesh

Abstract

This invention provides a pharmaceutical composition comprising a eutectic composition of two pharmacologically active ingredients for delivery to the lung by inhalation. This invention also provides a pharmaceutical composition comprising a eutectic composition of two pharmacologically active ingredients for the treatment of respiratory disease.

IPC Classes  ?

  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/00 - Medicinal preparations characterised by special physical form

5.

PROCESS FOR IMPROVING CRYSTALLINITY

      
Application Number GB2010051762
Publication Number 2011/048412
Status In Force
Filing Date 2010-10-20
Publication Date 2011-04-28
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Ruecroft, Graham
  • Parikh, Dipesh

Abstract

The invention provides a process for increasing the crystallinity of at least one solid material which is less than 100 % crystalline, comprising applying ultrasound to the substantially dry solid material.

IPC Classes  ?

  • B01D 9/00 - Crystallisation
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • B01B 1/00 - BoilingBoiling apparatus for physical or chemical purposes
  • A61K 9/00 - Medicinal preparations characterised by special physical form

6.

AN APPARATUS AND PROCESS FOR PRODUCING CRYSTALS

      
Application Number GB2010050007
Publication Number 2010/079350
Status In Force
Filing Date 2010-01-05
Publication Date 2010-07-15
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Ruecroft, Graham
  • Burns, John

Abstract

This invention provides an oscillating baffled reactor apparatus for preparing crystalline particles of at least one substance comprising: a reactor vessel; means for supplying a first flowing stream; means for oscillating fluid within the reactor vessel; a plurality of baffles; source of ultrasonic radiation; and means for collecting said particles.

IPC Classes  ?

  • B01J 19/00 - Chemical, physical or physico-chemical processes in generalTheir relevant apparatus
  • B01J 19/10 - Processes employing the direct application of electric or wave energy, or particle radiationApparatus therefor employing sonic or ultrasonic vibrations
  • B01J 19/18 - Stationary reactors having moving elements inside

7.

PROCESS FOR IMPROVING CRYSTALLINITY OF FLUTICASONE PARTICLES

      
Application Number GB2009050884
Publication Number 2010/007446
Status In Force
Filing Date 2009-07-20
Publication Date 2010-01-21
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Ruecroft, Graham
  • Parikh, Dipesh
  • Hipkiss, David

Abstract

This invention provides a process for increasing the crystallinity of at least one solid material comprising a fluticasone compound which is less than 100% crystalline, comprising contacting said solid material with solvent in which the solid material is insoluble or poorly soluble (a non-solvent); and applying ultrasound to the solid material when in contact with said non-solvent.

IPC Classes  ?

  • B01D 9/00 - Crystallisation
  • C30B 7/00 - Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • B01D 1/18 - Evaporating by spraying to obtain dry solids
  • F26B 5/06 - Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
  • F26B 3/12 - Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air the gas or vapour carrying the materials or objects to be dried with it in the form of a spray

8.

PROCESS FOR IMPROVING CRYSTALLINITY

      
Application Number GB2009050885
Publication Number 2010/007447
Status In Force
Filing Date 2009-07-20
Publication Date 2010-01-21
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Ruecroft, Graham
  • Parikh, Dipesh
  • Hipkiss, David

Abstract

This invention provides a process for increasing the crystallinity of at least one solid material which is less than 100% crystalline, comprising contacting said solid material with solvent in which the solid material is insoluble or poorly soluble (a non-solvent); and applying ultrasound to the solid material when in contact with said non-solvent.

IPC Classes  ?

  • B01D 9/00 - Crystallisation
  • C30B 7/00 - Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • B01D 1/18 - Evaporating by spraying to obtain dry solids
  • F26B 5/06 - Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
  • F26B 3/12 - Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air the gas or vapour carrying the materials or objects to be dried with it in the form of a spray

9.

UMAX

      
Application Number 142980300
Status Registered
Filing Date 2009-03-04
Registration Date 2012-03-07
Owner Prosonix Limited (United Kingdom)
NICE Classes  ?
  • 35 - Advertising and business services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Treating liquids, droplets of liquid, and particles with ultrasonic waves to modify their properties in the pharmaceutical industry and in the chemical industry; technical consultancy services in the field of ultrasonic treatment of liquids, droplets of liquid, and particles to modify their properties in the pharmaceutical industry and in the chemical industry.

10.

PROCESS FOR MAKING CRYSTALS

      
Application Number GB2008050452
Publication Number 2008/155570
Status In Force
Filing Date 2008-06-17
Publication Date 2008-12-24
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Ruecroft, Graham
  • Robinson, James
  • Parikh, Dipesh

Abstract

A process for preparing an emulsion or a dispersion comprising crystalline particles of at least one active principal that comprises contacting a solution of at least one solute in a solvent or mixture of solvents in a first flowing stream with a non-solvent in a second flowing stream wherein the non-solvent and solvent are not miscible with each other, so as to form an emulsion or a dispersion. Super saturation is brought about by suitable means, and the emulsion or dispersion is subjected to ultrasonic irradiation to mediate crystal nucleation.

IPC Classes  ?

  • B01D 9/00 - Crystallisation
  • B01J 2/02 - Processes or devices for granulating materials, in generalRendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
  • B01J 2/18 - Processes or devices for granulating materials, in generalRendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

11.

PROCESS FOR MAKING CRYSTALS

      
Application Number GB2008050191
Publication Number 2008/114052
Status In Force
Filing Date 2008-03-18
Publication Date 2008-09-25
Owner PROSONIX LIMITED (United Kingdom)
Inventor
  • Robinson, James
  • Ruecroft, Graham

Abstract

A process for preparing crystalline particles of an active principal in the presence of ultrasonic irradiation that comprises contacting a solution of a solute in a solvent in a first flowing stream with an anti-solvent in a second flowing stream causing the mixing thereof, wherein the flow rate ratio of the anti- solvent: solvent is higher than 20:1, and collecting crystals that are generated.

IPC Classes  ?

  • B01J 2/02 - Processes or devices for granulating materials, in generalRendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
  • B01J 2/18 - Processes or devices for granulating materials, in generalRendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
  • A61K 9/00 - Medicinal preparations characterised by special physical form